Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

PHOSPHONOALKYL PENYLALANINE COMPOUNDS SUITABLY PROTECTED FOR USE IN PEPTIDE SYNTHESIS

  • Read more about PHOSPHONOALKYL PENYLALANINE COMPOUNDS SUITABLY PROTECTED FOR USE IN PEPTIDE SYNTHESIS
US Patent 5,475,129
Filed on 1993-06-08

75 KILODALTON INTERLEUKIN-2 RECEPTOR PROTEINS AND THEIR USES

  • Read more about 75 KILODALTON INTERLEUKIN-2 RECEPTOR PROTEINS AND THEIR USES
US Patent 5,352,772
Filed on 1986-12-19

HEPATOCELLULAR CARCINOMA ONCOGENE

  • Read more about HEPATOCELLULAR CARCINOMA ONCOGENE
US Patent 5,811,262
Filed on 1994-10-18

CLONED HUMAN CRIPTO GENE AND APPLICATIONS THEREOF

  • Read more about CLONED HUMAN CRIPTO GENE AND APPLICATIONS THEREOF
US Patent 5,654,140
Filed on 1994-11-10

DIMERIC ARYLISOQUINOLINE ALKALOID COMPOUNDS

  • Read more about DIMERIC ARYLISOQUINOLINE ALKALOID COMPOUNDS
US Patent 5,578,729
Filed on 1994-12-23

Determining Kinase Specificity

  • Read more about Determining Kinase Specificity
US Application 10/660,370
Filed on 2003-09-11

CLONING AND EXPRESSION OF HTLV-III DNA

  • Read more about CLONING AND EXPRESSION OF HTLV-III DNA
US Application 08/080,387
Filed on 1993-06-21

P450DB1 CLONES FOR IDENTIFYING HUMANS WITH GENETIC DEFECT IN DRUG METABOLISM

  • Read more about P450DB1 CLONES FOR IDENTIFYING HUMANS WITH GENETIC DEFECT IN DRUG METABOLISM
US Patent 5,508,199
Filed on 1994-05-13

NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF A NEW TUMOR GENE, INT6, AND THE USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN DIAGNOSTIC...

  • Read more about NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF A NEW TUMOR GENE, INT6, AND THE USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN DIAGNOSTIC...
US Application 08/385,998
Filed on 1995-02-09

ENHANCED IMMUNE RESPONSE TO AN ANTIGEN BY A COMPOSITION OF A RECOMBINANT VIRUS EXPRESSING THE ANTIGEN WITH A RECOMBINANT VIRUS ...0

  • Read more about ENHANCED IMMUNE RESPONSE TO AN ANTIGEN BY A COMPOSITION OF A RECOMBINANT VIRUS EXPRESSING THE ANTIGEN WITH A RECOMBINANT VIRUS ...0
US Application 08/317,268
Filed on 1994-10-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1581
  • Page 1582
  • Page 1583
  • Page 1584
  • Page 1585
  • Page 1586
  • Page 1587
  • Page 1588
  • Page 1589
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health